Preparation of Functional Monoclonal Antibody Against Human B7-2 Molecule and Analysis of Its Biological Characteries
TAO Ran,SHI Yun-jie,SUN Zhong-wen,MA Hong-bing,XU Ying,CHENG Gang,SUN Wei-li,ZHOU Li-feng,QIU Yu-hua,ZHANG Xue-guang
DOI: https://doi.org/10.3969/j.issn.1001-2478.2006.03.006
2006-01-01
Abstract:The cell lines 1.929-B7-2, transfected human B7-2 gene, and Daudi, established from human B cell malignant lymphoma patient were taken as immunogen, pretreated with mitomycin, before being used to immunize BALB/c mice, and the splenocytes of immunized mice were used to fuse with murine myeloma cells SP2/0. One hybridoma, named 6A5, stably secreting monoclonal antihody against human B7-2 molecule was successfully obtained after repeated secreting and sub cloning culture. The subclass of 6A5 was mouse IgG1 with kappa light chains through fast-strip method analysis. Ascites were induced to produce monoclonal antibody and 5.9 ml ascites was obtained from each BAI.B/c mouse. The purified 6A5 from ascites was about 1.1 mg per ml ascites with affinity chromatography method. The 6A5 could specifically recognize membrane B7 2 molecules expressed on cells of 1.929-B7-2, PBTC, Raji and Daudi by indirect immunofluoresence and the positive percentage was 99.9%, 4.6%, 90.6%and 99.1%, respectively. In addition it could inhibit the growth and proliferation of Daudi cells and PBTC through blockade the B7-2 costimulatory signals with MTT assay. These results demonstrate that 6A5 is a funtionally specific monoclonal antibody for B7-2 molecule and has a high affinity for its ligands. It may be of significant value in basic studies and clinical applications.